Brief: Helix Biopharma Q2 loss per share C$0.03
16/03/2016 20:15
March 16 (Reuters) - Helix Biopharma Corp HBP.TO :
* Helix Biopharma Corp. announces second quarter fiscal 2016
results
* Q2 loss per share C$0.03
* Qtrly loss per share $0.03
Source text for Eikon: ID:nCCN7r61PQ
Further company coverage: HBP.TO
((Bengaluru Newsroom; +1 646 223 8780;))
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020